This is the text extract for Notification of acceptance of agreement with Fresenius Kabi., browse documents here.

31 August 2010

Agreement with Fresenius Kabi approved

PHARMAC is pleased to announce the approval of an agreement with Fresenius Kabi Australia Pty Limited for the listing and supply of sodium chloride infusions. This was the subject of a consultation letter dated 30 July 20101. In summary, the effect of our decision is that Freeflex (sodium chloride 0.9%), 500 ml and 1,000 ml bags will be listed from 1 November 2010 in Part II of Section H of the Pharmaceutical Schedule and PHARMAC will not be able to delist Freeflex prior to 1 July 2012. Freeflex will not have Hospital Supply Status, so DHB Hospitals can continue to purchase other brands should they choose to. Details of the proposal Freeflex will be listed in Part II of Section H of the Pharmaceutical Schedule from 1 November 2010 as follows:

Chemical Sodium chloride Sodium chloride Presentation Inf 0.9% Inf 0.9% Brand Freeflex Freeflex Pack size 500 ml 1000 ml Price $1.70 $1.71

Feedback received We appreciate all of the feedback that we received and acknowledge the time people took to respond. All consultation responses received by 14 August 2010 were considered in their entirety in making a decision on the proposed changes. Most responses were supportive of the proposal. More information If you have any questions about this decision, you can call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.

1

http://www.pharmac.govt.nz/2010/08/09/2010-0809%20Consultation%20on%20agreement%20with%20Multichem%20for%20sodium%20chloride.pdf

A375015 Page 1 of 1